121 related articles for article (PubMed ID: 11999575)
41. [Mismatch repair gene promoter methylation and expression in hydatidiform moles and the malignant transformation].
Zhu CK; Ye DF; Xie X; Cheng XD; Chen HZ; Lu WG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):422-6. PubMed ID: 12974087
[TBL] [Abstract][Full Text] [Related]
42. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer.
Kitajima Y; Miyazaki K; Matsukura S; Tanaka M; Sekiguchi M
Gastric Cancer; 2003; 6(2):86-95. PubMed ID: 12861399
[TBL] [Abstract][Full Text] [Related]
43. Immunohistochemical analysis of expression and allelotype of mismatch repair genes (hMLH1 and hMSH2) in bladder cancer.
Kassem HS; Varley JM; Hamam SM; Margison GP
Br J Cancer; 2001 Feb; 84(3):321-8. PubMed ID: 11161395
[TBL] [Abstract][Full Text] [Related]
44. Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
Catto JW; Xinarianos G; Burton JL; Meuth M; Hamdy FC
Int J Cancer; 2003 Jul; 105(4):484-90. PubMed ID: 12712438
[TBL] [Abstract][Full Text] [Related]
45. Expression of DNA mismatch repair proteins hMSH2 and hMLH1 and the cyclin G1 inhibitor, p21(waf1/cip1) in pediatric tumors: correlation with response to therapy.
Idikio HA
Oncol Rep; 2001; 8(5):965-71. PubMed ID: 11496300
[TBL] [Abstract][Full Text] [Related]
46. Defects of DNA mismatch repair in human prostate cancer.
Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW
Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical expression of DNA mismatch repair (MMR) system proteins (hMLH1, hMSH2) in cervical preinvasive and invasive lesions.
Ciavattini A; Piccioni M; Tranquilli AL; Filosa A; Pieramici T; Goteri G
Pathol Res Pract; 2005; 201(1):21-5. PubMed ID: 15807307
[TBL] [Abstract][Full Text] [Related]
48. Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas.
Vageli D; Daniil Z; Dahabreh J; Karagianni E; Vamvakopoulou DN; Ioannou MG; Scarpinato K; Vamvakopoulos NC; Gourgoulianis KI; Koukoulis GK
Lung Cancer; 2009 Jun; 64(3):282-8. PubMed ID: 19056144
[TBL] [Abstract][Full Text] [Related]
49. BAT-26 microsatellite instability does not correlate with the loss of hMLH1 and hMSH2 protein expression in sporadic endometrial cancers.
Miturski R; Bogusiewicz M; Tarkowski R; Ciotta C; Bignami M; Burnouf D; Jakowicki JA
Oncol Rep; 2003; 10(4):1039-43. PubMed ID: 12792767
[TBL] [Abstract][Full Text] [Related]
50. Immunocytochemical detection of hMSH2 and hMLH1 expression in oral melanoma.
Lo Muzio L; Nocini P; Mignogna MD; Pannone G; Staibano S; Procaccini M; Rubini C; Fioroni M; Fanali S; Piattelli A
Anticancer Res; 2000; 20(2A):741-8. PubMed ID: 10810349
[TBL] [Abstract][Full Text] [Related]
51. Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells.
Kim JJ; Tao H; Carloni E; Leung WK; Graham DY; Sepulveda AR
Gastroenterology; 2002 Aug; 123(2):542-53. PubMed ID: 12145807
[TBL] [Abstract][Full Text] [Related]
52. Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type.
Wang Q; Montmain G; Ruano E; Upadhyaya M; Dudley S; Liskay RM; Thibodeau SN; Puisieux A
Hum Genet; 2003 Feb; 112(2):117-23. PubMed ID: 12522551
[TBL] [Abstract][Full Text] [Related]
53. Analysis of the DNA mismatch repair proteins expression in malignant melanomas.
Korabiowska M; Brinck U; Dengler H; Stachura J; Schauer A; Droese M
Anticancer Res; 2000; 20(6B):4499-505. PubMed ID: 11205295
[TBL] [Abstract][Full Text] [Related]
54. Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer.
Zhang H; Zhang S; Cui J; Zhang A; Shen L; Yu H
Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):505-9. PubMed ID: 19032668
[TBL] [Abstract][Full Text] [Related]
55. Mismatch repair gene promoter methylation and expression in hydatidiform moles.
Chen H; Ye D; Xie X; Lu W; Zhu C; Chen X
Arch Gynecol Obstet; 2005 Jun; 272(1):35-9. PubMed ID: 15338238
[TBL] [Abstract][Full Text] [Related]
56. Apoptosis induced by overexpression of hMSH2 or hMLH1.
Zhang H; Richards B; Wilson T; Lloyd M; Cranston A; Thorburn A; Fishel R; Meuth M
Cancer Res; 1999 Jul; 59(13):3021-7. PubMed ID: 10397236
[TBL] [Abstract][Full Text] [Related]
57. Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variables.
Johannsdottir JT; Bergthorsson JT; Gretarsdottir S; Kristjansson AK; Ragnarsson G; Jonasson JG; Egilsson V; Ingvarsson S
Anticancer Res; 1999; 19(3A):1821-6. PubMed ID: 10470121
[TBL] [Abstract][Full Text] [Related]
58. Defective mismatch repair and the development of recurrent endometrial carcinoma.
Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG
Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202
[TBL] [Abstract][Full Text] [Related]
59. Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patients.
Taubert HW; Bartel F; Kappler M; Schuster K; Meye A; Lautenschläger C; Thamm-Mücke B; Bache M; Schmidt H; Holzhausen HJ; Würl P
Cancer; 2003 May; 97(9):2273-8. PubMed ID: 12712483
[TBL] [Abstract][Full Text] [Related]
60. BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair.
Wang L; Cunningham JM; Winters JL; Guenther JC; French AJ; Boardman LA; Burgart LJ; McDonnell SK; Schaid DJ; Thibodeau SN
Cancer Res; 2003 Sep; 63(17):5209-12. PubMed ID: 14500346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]